下一个

自动播放

Novel Agents and Combinations in Hodgkin Lymphoma

0 意见 • 07/09/23
分享
嵌入
administrator
administrator
订户
0

Panelists discuss novel agents, such as HDAC inhibitors, being explored in clinical trials for patients with Hodgkin lymphoma.

For more from this discussion, visit http://www.onclive.com/peer-exchange/lymphoma

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放